{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:50:54Z","timestamp":1711540254334},"reference-count":11,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"Supplement","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1536\/ihj.14-346","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T18:41:59Z","timestamp":1426704119000},"page":"S8-S11","source":"Crossref","is-referenced-by-count":3,"title":["Medical Treatment for an Adult Patient With Eisenmenger Syndrome"],"prefix":"10.1536","volume":"56","author":[{"given":"Atsushi","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fernandes SM, Newburger JW, Lang P, <i>et al<\/i>. Usefulness of epoprostenol therapy in the severely ill adolescent\/adult with Eisenmenger physiology. Am J Cardiol 2003; 91: 632-5.","DOI":"10.1016\/S0002-9149(02)03328-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gali\u00e8 N, Beghetti M, Gatzoulis MA, <i>et al<\/i>. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006; 114: 48-54.","DOI":"10.1161\/CIRCULATIONAHA.106.630715"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J 2006; 151: 851 e1-5.","DOI":"10.1016\/j.ahj.2005.09.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mukhopadhyay S, Sharma M, Ramakrishnan S, <i>et al<\/i>. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Circulation 2006; 114: 1807-10.","DOI":"10.1161\/CIRCULATIONAHA.105.603001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dimopoulos K, Inuzuka R, Goletto S, <i>et al<\/i>. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010; 121: 20-5.","DOI":"10.1161\/CIRCULATIONAHA.109.883876"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Iversen K, Jensen AS, Jensen TV, Vejlstrup NG, S\u00f8ndergaard L. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. Eur Heart J 2010; 31: 1124-31.","DOI":"10.1093\/eurheartj\/ehq011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zuckerman WA, Leaderer D, Rowan CA, Mituniewicz JD, Rosenzweig EB. Ambrisentan for pulmonary arterial hypertension due to congenital heart disease. Am J Cardiol 2011; 107: 1381-5.","DOI":"10.1016\/j.amjcard.2010.12.051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. D\u2019Alto M, Romeo E, Argiento P, <i>et al<\/i>. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. Int J Cardiol 2012; 155: 378-82.","DOI":"10.1016\/j.ijcard.2010.10.051"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wrishko RE, Dingemanse J, Yu A, Darstein C, Phillips DL, Mitchell MI. Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects. J Clin Pharmacol 2008; 48: 610-8.","DOI":"10.1177\/0091270008315315"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Paul GA, Gibbs JS, Boobis AR, Abbas A, Wilkins MR. Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension. Br J Clin Pharmacol 2005; 60: 107-12.","DOI":"10.1111\/j.1365-2125.2005.02383.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hatano M, Yao A, Kinugawa K, Hirata Y, Nagai R. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan. Int Heart J 2011; 52: 233-9.","DOI":"10.1536\/ihj.52.233"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:01:57Z","timestamp":1566432117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/56\/Supplement\/56_14-346\/_article"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":11,"journal-issue":{"issue":"Supplement","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.14-346","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}